Earnings on May 23, I see the shorts running for cover till then. Should be a very interesting day. GOOD LUCK
Sentiment: Strong Buy
Earnings will be out by next week, and if you are shorting ALKS you will experience what a short squeeze is.
Sentiment: Strong Buy
Earnings will be released in a matter of days, if you are so sure buy some put's. I'll stay long, "The best is yet to come"
Sentiment: Strong Buy
Was very impressive, all signs point up. No earnings date announced. From what I can find most think May 16th. Good luck too all.
I think earnings will have to be released prior to presentation, so they can use it as part of their presentation.should be a very interesting day.
Sentiment: Strong Buy
Wed. May 8th see ALKS EVENTS should be an interesting day
Sentiment: Strong Buy
I think earnings date will be announced this week, for release next week. Good luck to all.
Sentiment: Strong Buy
You are right on about analyst. We should see earnings date announced very soon?
Sentiment: Strong Buy
Earnings date should be announced in very few day's. Should be very interesting. "Don't fight the tape."
Buyers at this price are looking for a big winner. ALKS has so many things going for big gains.
Looks like Xmas is coming early for ALKS shareholders. A great phase two report, and you can bet big pharma is watching.
Sentiment: Strong Buy
Priced very low at this time relative to increased earnings, will be much higher by end of this year.
Sentiment: Strong Buy
ALKS is a great buy, and opportunity for an investor. Good income stream from royalties on drugs that have long patent protection, and huge growth posabilities. The best is yet to come.
Sentiment: Strong Buy
Type message
Sentiment: Strong Buy
Cramer mentioned ALKS on CNBC ABOUT AN HOUR AGO. I'm not sure if CEO of ALKS will be on or not. Getting a well deserved run up today. Best is yet too come.
Alkermes CEO will appear on Jim Cramer show today.
Sentiment: Strong Buy
Just listened to todays webcast. ALKS offers one of the best investment opportunities that I have seen. A very good opportunity to save for future retirement.
Sentiment: Strong Buy
NVO delay in their long acting insulin drug should give BMY a big edge in getting a great start on Bydureon, helping ALKS with Bydureon royalties.
Sentiment: Strong Buy
I agree. BIIB purchase of drug from ELN for 3.25 billion shows what ALKS purchase of ELN tech. was worth. Price of ALKS should start moving up after presentation. GOOD LUCK
Sentiment: Strong Buy
BIIB shows how much drug technology ALKS purchased from ELN is worth. Hope sale of ALKS shares by ELN has been completed.
Sentiment: Strong Buy